These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 1761067)
1. Effect of nifedipine on glucose potentiation of the acute insulin response to arginine in non-insulin-dependent diabetics. Krempf M; Ranganatan S; Ritz P; Garnier JM; Charbonnel B Eur J Clin Pharmacol; 1991; 41(5):411-5. PubMed ID: 1761067 [TBL] [Abstract][Full Text] [Related]
2. Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. Ward WK; Bolgiano DC; McKnight B; Halter JB; Porte D J Clin Invest; 1984 Oct; 74(4):1318-28. PubMed ID: 6384269 [TBL] [Abstract][Full Text] [Related]
3. Effect of nifedipine, captopril and prazosin on secretory function of pancreatic beta-cells in hypertensive patients with type-2 (non-insulin-dependent) diabetes and in hypertensive non-diabetics. Jasik M; Kasperska-Dworak A; Czyzyk A Diabetes Res Clin Pract; 1996 Jun; 33(1):59-66. PubMed ID: 8877277 [TBL] [Abstract][Full Text] [Related]
5. A role for endogenous prostaglandins in defective glucose potentiation of nonglucose insulin secretagogues in diabetics. McRae JR; Metz SA; Robertson RP Metabolism; 1981 Nov; 30(11):1065-75. PubMed ID: 7026970 [TBL] [Abstract][Full Text] [Related]
6. Effect of epinephrine on pancreatic beta-cell and alpha-cell function in patients with NIDDM. Ortiz-Alonso FJ; Herman WH; Zobel DL; Perry TJ; Smith MJ; Halter JB Diabetes; 1991 Sep; 40(9):1194-202. PubMed ID: 1936624 [TBL] [Abstract][Full Text] [Related]
7. Quantitative and qualitative differences in basal and glucose- and arginine-stimulated insulin secretion in healthy subjects and different stages of NIDDM. Ratheiser K; Reitgruber W; Komjati M; Bratusch-Marrain P; Vierhapper H; Waldhäusl WK Acta Diabetol Lat; 1990; 27(3):197-213. PubMed ID: 2075783 [TBL] [Abstract][Full Text] [Related]
8. Chronic chlorpropamide therapy of noninsulin-dependent diabetes augments basal and stimulated insulin secretion by increasing islet sensitivity to glucose. Judzewitsch RG; Pfeifer MA; Best JD; Beard JC; Halter JB; Porte D J Clin Endocrinol Metab; 1982 Aug; 55(2):321-8. PubMed ID: 7045153 [TBL] [Abstract][Full Text] [Related]
9. Pathophysiology of insulin secretion in diabetes mellitus. Ward WK; Beard JC; Halter JB; Porte D Adv Exp Med Biol; 1985; 189():137-58. PubMed ID: 3898762 [TBL] [Abstract][Full Text] [Related]
10. Insulin secretion and glucose tolerance in non-insulin dependent diabetic patients after chronic nifedipine treatment. Tentorio A; Ghilardi G; Pedroncelli A; Benco R; Stroppa S; Adib S; Gianola D; Pagani G Eur J Clin Pharmacol; 1989; 36(3):311-3. PubMed ID: 2663524 [TBL] [Abstract][Full Text] [Related]
11. Arginine induced insulin release in patients with newly onset non-insulin-dependent diabetes mellitus. Cheng HM; Jap TS; Lee KT; Kwok CF; Ho LT Zhonghua Yi Xue Za Zhi (Taipei); 1992 Sep; 50(3):184-8. PubMed ID: 1330242 [TBL] [Abstract][Full Text] [Related]
12. Decreased insulin secretory capacity and normal pancreatic B-cell glucose sensitivity in non-obese patients with NIDDM. Van Haeften TW; Van Maarschalkerweerd WW; Gerich JE; Van der Veen EA Eur J Clin Invest; 1991 Apr; 21(2):168-74. PubMed ID: 1905629 [TBL] [Abstract][Full Text] [Related]
13. Effects of nifedipine on insulin secretion and glucose metabolism in rats and in hypertensive type 2 (non-insulin dependent) diabetics. Kanatsuna T; Nakano K; Mori H; Kano Y; Nishioka H; Kajiyama S; Kitagawa Y; Yoshida T; Kondo M; Nakamura N Arzneimittelforschung; 1985; 35(2):514-7. PubMed ID: 3888227 [TBL] [Abstract][Full Text] [Related]
14. Glucose potentiation of arginine-induced insulin secretion is impaired in subjects with a glucokinase Glu256Lys mutation. Wajngot A; Alvarsson M; Glaser A; Efendic S; Luthman H; Grill V Diabetes; 1994 Dec; 43(12):1402-6. PubMed ID: 7958490 [TBL] [Abstract][Full Text] [Related]
15. Arginine-stimulated acute phase of insulin secretion in non-insulin-dependent diabetes in the young. Naidoo C; Jialal I; Joubert SM Diabetes Res; 1986 Mar; 3(3):127-9. PubMed ID: 3519045 [TBL] [Abstract][Full Text] [Related]
16. Insulin treatment improves glucose-induced insulin release in rats with NIDDM induced by streptozocin. Kergoat M; Bailbe D; Portha B Diabetes; 1987 Aug; 36(8):971-7. PubMed ID: 3297892 [TBL] [Abstract][Full Text] [Related]
17. Insulin responses to nonglucose stimuli in non-insulin-dependent diabetes mellitus during a tolbutamide infusion. Pfeifer MA; Halter JB; Beard JC; Judzewitsch R; Porte D Diabetes; 1982 Feb; 31(2):154-9. PubMed ID: 6759232 [TBL] [Abstract][Full Text] [Related]
18. [Insulin resistance and insulin secretion in type II non-obese diabetics]. Pelikánová T; Válek J; Kazdová L; Saudek F; Karasová L Cas Lek Cesk; 1994 Mar; 133(6):172-6. PubMed ID: 8156572 [TBL] [Abstract][Full Text] [Related]
19. Time-dependent inhibition of insulin release: suppression of the arginine effect by hyperglycaemia. Nesher R; Tuch B; Hage C; Levy J; Cerasi E Diabetologia; 1984 Feb; 26(2):142-5. PubMed ID: 6370761 [TBL] [Abstract][Full Text] [Related]
20. Defects in beta-cell function and insulin sensitivity in normoglycemic streptozocin-treated baboons: a model of preclinical insulin-dependent diabetes. McCulloch DK; Raghu PK; Johnston C; Klaff LJ; Kahn SE; Beard JC; Ward WK; Benson EA; Koerker DJ; Bergman RN J Clin Endocrinol Metab; 1988 Oct; 67(4):785-92. PubMed ID: 3047163 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]